Search Within

Andrew Joseph Plodkowski

  1. "GSK Faculty"
Formats
  1. Journal Article (30)
  2. Meeting Abstract (14)
Groups
  1. Body Imaging Service (44)
  2. Department of Medicine (44)
  3. GSK Faculty (44)
  4. Radiology, Department of (44)
  5. Solid Tumor Oncology Division (44)
  6. Thoracic Oncology (43)

More Groups

People
  1. Charles Rudin (32)
  2. Mark Kris (25)
  3. Gregory Riely (23)
  4. Marc Ladanyi (22)
  5. Matthew Hellmann (22)
  6. Hira Rizvi (17)

More People

Years
  1. 2024 (1)
  2. 2023 (7)
  3. 2022 (3)
  4. 2021 (2)
  5. 2020 (8)
  6. 2019 (8)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. Clinical Cancer Research (8)
  3. Journal of Thoracic Oncology (8)
  4. Annals of Oncology (4)
  5. Cancer Cell (2)
  6. Cancer Discovery (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (13)
  2. American Association for Cancer Research (11)
  3. Elsevier Inc. (9)
  4. Oxford University Press (5)
  5. Cell Press (2)
  6. Biomed Central Ltd (1)

More Publishers

Results (44)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immune biomarkers and response to checkpoint inhibition of BRAF(V600) and BRAF non-V600 altered lung cancers
    Journal Article

    Murciano-Goroff, Y. R.; Pak, T.; Mondaca, S.; Flynn, J. R.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Plodkowski, A. J.; Wu, S. L.; Kris, M. G.; more...
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Risk stratification of cardiac metastases using late gadolinium enhancement cardiovascular magnetic resonance: Prognostic impact of hypo-enhancement evidenced tumor avascularity
    Journal Article

    Chan, A. T.; Dinsfriend, W.; Kim, J.; Yum, B.; Sultana, R.; Klebanoff, C. A.; Plodkowski, A.; Perez Johnston, R.; Ginsberg, M. S.; Liu, J.; more...
    Journal of Cardiovascular Magnetic Resonance (2021)

    Fulltext@MSK | Save
  • Treatment outcomes and clinical characteristics of patients with KRAS-G12C-mutant non-small cell lung cancer
    Journal Article

    Arbour, K. C.; Rizvi, H.; Plodkowski, A. J.; Hellmann, M. D.; Knezevic, A.; Heller, G.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; Arcila, M. E.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Phase II study of TAK228 in patients with advanced non-small cell lung cancer (NSCLC) harboring NFE2L2 and KEAP1 mutations
    Meeting Abstract

    Paik, P. K.; Ahn, L. S. H.; Plodkowski, A. J.; Fan, P. D.; Rudin, C. M.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Long-term responders to PD-1 blockade in patients with advanced non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Luo, J.; Bandlamudi, C.; Ricciuti, B.; Vokes, N.; Schoenfeld, A. J.; Egger, J. V.; Sauter, J. L.; Plodkowski, A. J.; Preeshagul, I. R.; Kris, M. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Molecular subtypes and clinical outcomes to initial systemic treatment in patients with small cell lung cancer
    Meeting Abstract

    Lai, W. C. V.; Egger, J. V.; Rizvi, H.; Richards, A. L.; Beras, A.; Baine, M. K.; Hsieh, M. S.; Chang, J. C.; Rekhtman, N.; Plodkowski, A. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Clinical characteristics and anti-PD-(L)1 treatment outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer
    Meeting Abstract

    Arbour, K. C.; Rizvi, H.; Plodkowski, A. J.; Halpenny, D.; Hellmann, M. D.; Heller, G.; Knezevic, A.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L)1 blockade in NSCLC
    Journal Article

    Hellmann, M. D.; Nabet, B. Y.; Rizvi, H.; Chaudhuri, A. A.; Wells, D. K.; Dunphy, M. P. S.; Chabon, J. J.; Liu, C. L.; Hui, A. B.; Arbour, K. C.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas
    Journal Article

    Schoenfeld, A. J.; Rizvi, H.; Bandlamudi, C.; Sauter, J. L.; Travis, W. D.; Rekhtman, N.; Plodkowski, A. J.; Perez-Johnston, R.; Sawan, P.; Beras, A.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • A phase II trial of albumin-bound paclitaxel and gemcitabine in patients with newly diagnosed stage IV squamous cell lung cancers
    Journal Article

    Paik, P. K.; Kim, R. K.; Ahn, L.; Plodkowski, A. J.; Ni, A.; Donoghue, M. T. A.; Jonsson, P.; Villalona-Calero, M.; Ng, K.; McFarland, D.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save